Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients

BACKGROUND: The adapted systemic inflammation score (aSIS), calculated from serum albumin and the lymphocyte‐to‐monocyte ratio, has been reported to be a novel prognostic marker for some types of cancers. However, the prognostic impact of aSIS in patients with esophageal squamous cell carcinoma (ESC...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomoto, Daichi, Baba, Yoshifumi, Akiyama, Takahiko, Okadome, Kazuo, Iwatsuki, Masaaki, Iwagami, Shiro, Miyamoto, Yuji, Yoshida, Naoya, Watanabe, Masayuki, Baba, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452479/
https://www.ncbi.nlm.nih.gov/pubmed/34585051
http://dx.doi.org/10.1002/ags3.12464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452479/
https://www.ncbi.nlm.nih.gov/pubmed/34585051
http://dx.doi.org/10.1002/ags3.12464

Ejemplares similares